Abbott Laboratories will withdraw its diet pill Meridia in the U.S. and Canada, after coming under pressure because the drug increases the risk of heart attack and stroke. FDA scientists requested the withdrawal because Meridia’s risks were not outweighed by any real benefit. European regulators pulled the product off the…
The U.S. Supreme Court rejected a drug company’s appeal to block an Arkansas defective drug trial to assess punitive damages. The Court also let stand a compensatory damage award for 2.75 million in the case of a woman who got breast cancer after taking hormone replacement therapy. The Plaintiff alleged…
The U.S. Supreme Court gave a victory to patient lawsuits against drugmakers, upholding a $7 million award to a woman who lost her arm after being injected with Wyeth’s Phenergan nausea treatment. The Court, in Wyeth v. Levine, voting 6-3, said patients can use state product liability statutes to bring…